Natalie Wildenradt | IR |
Geraldine Henwood | President and CEO |
Ryan Lake | CFO |
Leland Gershell | Oppenheimer & Co |
Scott Henry | Roth Capital |
Kenneth Trbovich | Janney |
Patrick Trucchio | Berenberg Capital Market |
Good day, ladies and gentlemen, and welcome to the Recro Pharma Third Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions].
As a reminder, this call is being recorded.